| Literature DB >> 23834747 |
Rachel Chester1, Lee Shepstone, Helena Daniell, David Sweeting, Jeremy Lewis, Christina Jerosch-Herold.
Abstract
BACKGROUND: People suffering from musculoskeletal shoulder pain are frequently referred to physiotherapy. Physiotherapy generally involves a multimodal approach to management that may include; exercise, manual therapy and techniques to reduce pain. At present it is not possible to predict which patients will respond positively to physiotherapy treatment. The purpose of this systematic review was to identify which prognostic factors are associated with the outcome of physiotherapy in the management of musculoskeletal shoulder pain.Entities:
Mesh:
Year: 2013 PMID: 23834747 PMCID: PMC3717132 DOI: 10.1186/1471-2474-14-203
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1PRISMA Flow chart outlining the literature search and study selection.
Study characteristics (divided into 3 sections according to study design)
| Controlled Trial (CT), 2 groups diff. @ start receive same PT | Aydogan 2003/2004 [ | S:n = 48 F:n = NS A:60 ± 7 & 58 ± 10 (44–80) D:≥3 m | Adhesive Capsulitis | Pain, active and passive ROM, Constant Score | i) On completion of PT course at 4 wks, ii) 3 m after D/C | UTD | Home exs, Stretches (Home and physiotherapist applied), Pulsed ultrasound, TNS | 4w, 3 m HEP | 20 | UTD | UTD | UTD | UTD |
| CT, 2 groups diff. @ start receive same PT | Kim 2004 [ | S:n = 90 F:n = 81 A:PLJG 24(19–31),PFJG 25(18–29) D:PLJG 4 ± 4,PFJG 3 ± 4y | Posterior Inferior Instability | UCLA, ASES, ROWE, Pain | 6 m (range 4–7) | 10% | Supervised and home exercises | 6 m (range 4–7) | UTD | UTD | 100 | 90 | 70 |
| RCT, 2 groups similar @ start receive different PT | Conroy 1998 [ | S:n = 7 + 7, F:n = UTD A:51(17)&55(10) D:NS | Shoulder Impingement Syndrome (Primary) | Pain, AROM sh Fl, Abd, IR, ER & scap. plane El, pain, functional Ax | 1-3 d after completion of PT course at 3 wks | UTD | Supervised/HEP, advise, heat, massage, DTFs, soft tissue mobs, 1 group received "Maitland" mobs to sh. | 3 w | 9 | UTD, (Incl exs 45-60mins, hotpacks 15 mins) | UTD | 96 | 82 |
| RCT, 2 groups similar at start receive different PT | Engebretsen 2010 [ | S:n = 104 F:n = 102; A:48 ± 11y D:3-6 m 33%, 6-12 m 29%, >12 m 39% | Sub-acromial Impingement Syndrome | SPADI; working/not working | 1 year | 10%-12% | 1) Advice and supervised exercises or 2) extracorporeal shockwave therapy. | Gp 1) ≤ 12 w Gp 2) 4–6 w | 1) Median 15 (IQR 11–16) 2) median 5 (IQR 4–6) | Gp 1) 45 m Gp 2) NS | ≥98 | 90-96 | UTD |
| RCT, 3 gps similar @ start receive different PT | Tanaka 2010 [ | S:n = 120 F:n = 110 A:64 ± 9y D:<1 m 34%, <3 m 35%, <6 m 19%, <7 m 12% | Adhesive Capsulitis | Change in active range of shoulder abduction | When improvement in O/C plateaued > 1 m (mean 5.9 ± 1.3 m) | 8% | Manual therapy to the shoulder, home exercises | 5 ± 1 m | 3 groups i) >2× w ii) 1× w iii) < 1× w | 40 mins | UTD | UTD | 53 |
| Cohort | Deutscher 2009 [ | S:n = NS, F:n = 5252 A:56 ± 15 D :0-21d 15% 22-90d 38% >90d 47% | NS | Functional Status using CAT [ | On completion of PT course | ~61% of full pop'n | At PT's discretion: advice, US, heat/ice, DTF, home/sup'd/class exercises, electrotherapy, MT, sh jt or soft tissue mobs | 8 ± 6w | 9 ± 6 | 26 ± 8 mins | 95-100 | 98 | 70 good, 14 mod |
| Cohort | Griggs 2000 [ | S:n = 75, F:n = 71 A:53(35–76) D:9(1–47)m | Adhesive Capsulitis (idiopathic phase II, P & limited ROM) | DASH, SF-36, Pain, active and passive ROM and SST | At i) 6–12 ws ii) 22 (12–41)m | 4% at 22 m | Home exs, 68 (91%) patients participated in supervised exercise programme | UTD | NS | UTD | 91 | UTD | mean 2× of recomm-ended 5 × daily |
| Cohort | Hung 2010 [ | S:n = 33 F:n = 32; A:20-33y, D:“improvers” 23 ± 18 m,“non improvers” 29 ± 15 m | Sub-acromial Impingement Syndrome | GROC | On completion of PT course at 6 wks | 3%, n = 1 | Exercises, manual therapy to shoulder & patient applied stretches | 6 wks | ≤12 | UTD | 97 | >80 | UTD |
| Cohort | Kennedy 2006 [ | S:n = 361 F:289 A:50 ± 15 D: <4w 24%, 4-12w 25%, >12w 49%, missing 3% | Actively not sub-classified. Soft tissue, pain/dis-comfort, 8% post surgery. | DASH | Max 12 weeks or discharge from PT if earlier | 20% | UTD | ≤12 wks | Mean 15 (±9) | UTD | 100 | UTD | UTD |
| Cohort | Mao 1997 [ | S:n = 18 → 12 F:n = 12 A:52(32–65) D:2-12 m | Adhesive Capsulitis | Range of movement (?active or passive) | After PT | UTD | Supervised and home exs, manual therapy to shoulder, electrotherapy | 4-6 wks | 2-3 × a week (8 to 18) | UTD | 100 | UTD | UTD |
| Cohort | Mintken 2010 [ | S:n = 80 F:n = 79 A:41 ± 13y D:511 ± 1503d | Mechanical Shoulder Pain | GROC, days off work 48 hrs after initial PT | 2nd or 3rd appointment over several days | <1% | MT to cervicothoracic spine and spinal mob'g exercises | <2 wks | 2 or 3 | Techniques <15 mins | 100 | 99 | UTD |
| Cohort | Ryall 2007 [ | S:n = 165 F:132 A:15–44 29%, 45–54 33%, 55–64 38% | Actively not sub-classified | Pain | 1, 3, 6 & 12 months | 20% | Physio’s discretion | UTD | UTD | UTD | UTD | UTD | UTD |
| Cohort | Sindhu 2012 [ | S:n = 3362 F:n = 1946-1519 A:54 ± 16y D: <22d 19% 22-90d 32%,% < 90d 49% | Musculo-skeletal conditions of the shoulder | Functional status using CAT [ | On discharge from PT | 43%-53% | UTD | UTD | UTD | UTD | UTD | UTD | NS |
| Cohort | Tyler 2010 [ | S:n = 22 F:n = 22 A:41 ± 13y D:5 ± 5 (1-24mo) | Posterior Impingement | Simple shoulder test | On discharge | 0% | MT to shoulder and home exercises | 7 ± 2 wks (3–12) | UTD | UTD | 100 | UTD | UTD |
| Cohort | Virta 2009 [ | S:n = 97 F:n = 72 A:50, median 51 (24–80) D:1-36mo | Shoulder Impingement Syndrome | UCLA | UTD | 26% | Supervised and PT facilitated exercises and home exercises | Mean 8 wks | Mean 11 | 1 hr | UTD | 74 | UTD |
| Cohort | Yang 2008 [ | S:n = 40 F:n = 34 A:54 ± 6(41–65)y D:6 ± 8 m (range 3–9 m) | Adhesive Capsulitis | FLEX-SF | 3 months | 15% | MT to shoulder, electrotherapy, supervised exes and PT app’d stretches | 3 mo | ~24, (2× w) | UTD | 100 | 85 | NA |
Legend: SD standard deviation, Durat’n duration, Proport’n proportion, NS Not stated, years, m months, w weeks, hr hour, d days, mins minutes, UTD unable to determine, ROM range of movement, AROM active range of movement, jt joint, PT physiotherapy, HEP Home exercise programme, DTF deep transverse frictions, MT Manual therapy, US Ultrasound, D/C Discharge, PLJG Painless jerk group, PFJG Painful jerk group, sh shoulder, Fl flexion, Abd abduction, Scap scapula, El Elevation, exs exercises, popn population, sup’d supervised.
Quality assessment of external validity, risk of bias, and presentation of results
| 1 | Aydogan 2003/2004 [ | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| | Kim 2004 [ | 0.5 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0.5 | 1 | 0 | 1 | 1 | 0 | 0 | 15.5 |
| 2 | Conroy 1998 [ | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
| Engebretsen 2010 [ | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 18 | |
| | Tanaka 2000 [ | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 14 |
| 3 | Deutscher 2009 [ | 1 | 0 | 0.5 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0.5 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 16 |
| Griggs 2000 [ | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6 | |
| Hung 2010 [ | 0 | 0.5 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0.5 | 1 | 0 | 0 | 1 | 1 | 1 | 16 | |
| Kennedy 2006 [ | 1 | 0.5 | 0.5 | 0.5 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0.5 | 1 | 1 | 1 | 14 | |
| Mao 1997 [ | 0 | 0.5 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 1 | 8 | |
| Mintken 2010 [ | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 18 | |
| Ryall 2007 [ | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0.5 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 13.5 | |
| Sindhu 2012 [ | 1 | 0 | 0.5 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | |
| Tyler 2010 [ | 0 | 0.5 | 0 | 1 | 1 | 0.5 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9 | |
| Virta 2009 [ | 0 | 0.5 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.5 | |
| Yang 2008 [ | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0.5 | 1 | 0 | 0 | 1 | 1 | 1 | 15.5 |
Section 1: Two groups, different at baseline, receive the same treatment; Section 2: Randomised controlled trials; Section 3: Cohort studies.
0 = No or unable to determine, 1 = Yes or not applicable, 0.5 = In part, to an extent that neither 0 or 1 applicable.